Doravirine: A Newer NNRTI Explained

Doravirine is a newer member of the NNRTI class, developed to offer the benefits of that class with a more favourable profile than older options. This guide explains what doravirine is, how it works, how it compares with earlier NNRTIs such as efavirenz, and the points a treating doctor keeps under review.

Doravirine is sometimes abbreviated to DOR, and it is available both on its own and within a single-tablet regimen.

Important note Buy 3 HIV Medicines & Get Free Delivery  This article is general information about medicines used in HIV care. It does not include dosing instructions and is not a substitute for medical advice. All HIV medicines are prescription-only and are selected, started, and changed by a qualified doctor.

Quick Summary / Key Takeaways Doravirine is a newer NNRTI that blocks the enzyme HIV uses to copy itself. It was developed to improve on the profile of older NNRTIs. It has fewer nervous system effects than efavirenz. It is available on its own and within a single-tablet regimen. It is prescription-only and always used in combination.

Doravirine is a newer member of the NNRTI class, developed to offer the benefits of that class with a more favourable profile than older options. Doravirine is sometimes abbreviated to DOR.

What Is Doravirine?

Doravirine belongs to the NNRTI class described in the guide to NNRTIs: efavirenz and nevirapine. Like others in the class, it attaches to reverse transcriptase and changes its shape so the enzyme can no longer function.

How Doravirine Compares With Older NNRTIs

Doravirine was developed to address some of the considerations associated with earlier NNRTIs. Compared with efavirenz, it is generally associated with fewer nervous system effects and a more favourable effect on cholesterol measures.

Feature	Doravirine	Efavirenz
Class	NNRTI	NNRTI
Nervous system effects	Fewer reported	More commonly reported
Effect on cholesterol	Generally favourable	Less favourable
Single-tablet option	Available	Available
Place in treatment	A newer option	Long established

Where Doravirine Is Used

• As part of combination treatment where an NNRTI-based regimen is suitable.
• Within a single-tablet regimen combining it with two NRTIs.
• As an option when a regimen is being reviewed, discussed in second-line ART and when to switch.

For most people starting treatment today, current guidance points to regimens built around dolutegravir, as set out in first-line ART regimens explained.

Common Side Effects

Doravirine is generally well tolerated. Where effects occur, they are usually mild and may include nausea, headache, dizziness (generally less often than with older NNRTIs), and unusual dreams or sleep changes (generally less often than with older NNRTIs).

Safety Points Doctors Monitor

• How treatment is tolerated in the early weeks.
• Interactions with other medicines, covered in drug interactions with ART, including certain medicines that lower doravirine levels.
• Treatment response, tracked through CD4 and viral load testing.

Myths vs Facts: Doravirine

Myth	Fact
Doravirine can be taken on its own.	It is used in combination as part of a complete regimen.
All NNRTIs have the same side effects.	Doravirine has fewer nervous system effects than older NNRTIs.
Newer means less studied and less reliable.	Doravirine is well studied and used within established guidance.
Doravirine has no interactions.	Certain medicines lower its levels, so a doctor reviews everything being taken.
An NNRTI is always the first choice.	Current guidance prefers dolutegravir-based regimens for most people.

When to Consult a Doctor Medical advice is appropriate before starting or changing doravirine, where side effects appear or persist, and where other medicines are being taken that may affect its levels. Support is available through HIV treatment and ART care.

Conclusion

Doravirine is a newer NNRTI developed to offer fewer nervous system effects and a more favourable effect on cholesterol than older options. While current guidance prefers dolutegravir-based treatment for most people, doravirine provides a useful alternative decided by the treating doctor.

For expert guidance, TAAL+ Healthcare offers HIV treatment & ART care and a confidential HIV doctor consultation.

Frequently Asked Questions

What is doravirine?

Doravirine is a newer NNRTI used as part of combination HIV treatment. It blocks reverse transcriptase and was developed to improve on the profile of older NNRTIs.

How does doravirine compare with efavirenz?

Doravirine is generally associated with fewer nervous system effects and a more favourable effect on cholesterol. Both are NNRTIs available within single-tablet regimens, and a doctor assesses suitability individually.

What are the side effects of doravirine?

It is generally well tolerated. Where effects occur they are usually mild and may include nausea, headache, and dizziness, with nervous system effects reported less often than with older NNRTIs.

Is doravirine taken as a single tablet?

Doravirine is available both on its own and within a single-tablet regimen combining it with two NRTIs.

Does doravirine interact with other medicines?

Certain medicines can lower doravirine levels, so the treating doctor reviews everything being taken before starting or changing treatment.

Is doravirine a first-line treatment?

Current guidance prefers dolutegravir-based regimens for most people. Doravirine is a useful alternative where an NNRTI-based regimen is considered suitable.

Is doravirine taken alone?

No. Like all antiretroviral medicines it is used as part of a combination regimen.

Is doravirine well studied?

Yes. Although it is a newer NNRTI, doravirine is well studied and used within established treatment guidance.